SORT BY Relevancy
The Nelson Group World Wide are launch experts. CEO and Founder Rooney Nelson’s extensive resume includes launching, the most successful pharmaceutical launch and one of the top global launches in history. He also launched Celebrex in Europe, Asia and Latin America, driving it to become the most successful and largest pain franchise across the globe. TNG has launched ground breaking and record setting initiatives and campaigns for many of the worlds biggest and most successful companies, brands and individuals using a patented and globally proven suite of launch tools, exclusively developed and used by TNG, known as Penetration Point Marketing. With Penetration Point Marketing, the first and most important breakthrough the TNG team delivers for their clients is leading them through a comprehensive, iterative and sometimes even fun process to truly identify and commit to their penetration point. That penetration point is the single most unique, different, tangible and achievable feature or benefit of their product that will revolutionize the market and bring them wild success. Conversely, inability to identify and focus on it guarantees their failure. Once that critical task is accomplished, TNG then helps their clients to develop proven, easy to measure, actionable strategies and tactics that will ensure that the product’s penetration point is completely compelling to future customers. Failure happens to 8 or 9 of every 10 products that are launched with generally catastrophic consequences for their teams. Avoid being the next casualty. As TNG’s track record has proven, if you really want to succeed in today’s very competitive and challenging marketplace, then simply never, ever, launch anything without them.
The actions of Merck went beyond the bounds of anything seen before in the pharmaceutical industry. To say Merck merely bent the rules is quite an understatement,” says leading pharmaceutical industry expert and thirty year veteran, Tom Nesi, author of a new book POISON PILLS: THE UNTOLD STORY OF VIOXX DRUG SCANDAL (St Martin’s Press, September 17, 2008). This new book reveals little known details about the pharmaceutical giant Merck’s tactics in aggressively marketing drugs -- from bribing doctors to endorse a drug, ignoring and delaying research, to intimidating and threatening scientists. Even five years after Merck took Vioxx off the market for causing fatal harm to patients; new evidence reported by The New York Times finds that the pharmaceutical industry and the FDA continue to play Russian roulette with patients and their health.
Join Host Live Chats
There are no live chats in progress